Transdermal Nicotine Well-Tolerated for Pulmonary Sarcoidosis and May Improve Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis
Chest 2021 May 21;[EPub Ahead of Print], ED Crouser, RM Smith, DA Culver, MW Julian, K Martin, J Baran, C Diaz, BS Erdal, EM HadeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.